Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. - Furie, R; Stohl, W; Ginzler, EM (Arthritis Res Ther, 2008)
et al.